World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
52
Citations
13418
World Ranking
2416
National Ranking
1192

Paul Hasty publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Paul Hasty sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 129 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Paul Hasty D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Paul Hasty sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 52 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Paul Hasty is affiliated with The University of Texas Health Science Center at San Antonio in the United States. Their research predominantly lies within the field of Biochemistry, Genetics and Molecular Biology, with notable contributions in Molecular Biology, Genetics, Oncology, Cancer Research, and Pathology and Forensic Medicine.

The scientist has explored multiple key topics in their work, including:

  • DNA Repair Mechanisms
  • CRISPR and Genetic Engineering
  • Digestive system and related health
  • PI3K/AKT/mTOR signaling in cancer
  • PARP inhibition in cancer therapy
  • Genetic factors in colorectal cancer
  • Telomeres, Telomerase, and Senescence

Noteworthy recent publications by Paul Hasty cover a range of subjects in cancer biology and aging, including:

  • Rapamycin Extends Life Span in Apc Colon Cancer FAP Model (2020), published in Clinical Colorectal Cancer
  • Persistent NF-κB activation in muscle stem cells induces proliferation-independent telomere shortening (2021), published in Cell Reports
  • Acarbose improved survival for Apc+/Min mice (2020), published in Aging Cell
  • Musashi1 Contribution to Glioblastoma Development via Regulation of a Network of DNA Replication, Cell Cycle and Division Genes (2021), published in Cancers
  • Sex-dependent lifespan extension of ApcMin/+ FAP mice by chronic mTOR inhibition (2020), published in Aging Pathobiology and Therapeutics

The scientist frequently publishes in several peer-reviewed venues including Cell Reports, Clinical Colorectal Cancer, Aging Cell, Cancers, and Aging Pathobiology and Therapeutics.

Paul Hasty collaborates regularly with several co-authors, indicating a collaborative research approach. Frequent collaborators include Sherry G. Dodds, Manish Parihar, Z. Dave Sharp, Mi-Young Son, and Gene B. Hubbard.

Best Publications

  • Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene

    Paul Hasty;Paul Hasty;Allan Bradley;Julia H. Morris;Diane G. Edmondson

  • Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

    Shyam K. Sharan;Masami Morimatsu;Masami Morimatsu;Urs Albrecht;Dae Sik Lim

  • A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53.

    Dae Sik Lim;Paul Hasty

  • Aging and Genome Maintenance: Lessons from the Mouse?

    Paul Hasty;Judith Campisi;Judith Campisi;Jan Hoeijmakers;Harry van Steeg

  • Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates

    Chengming Zhu;Molly A. Bogue;Dae Sik Lim;Paul Hasty

  • Introduction of a subtle mutation into the hox-2.6 locus in embryonic stem cells

    Paul Hasty;Ramiro Ramírez-Solis;Robb Krumlauf;Allan Bradley

  • Deletion of Ku86 causes early onset of senescence in mice.

    Hannes Vogel;Dae Sik Lim;Gerard Karsenty;Milton Finegold

  • The length of homology required for gene targeting in embryonic stem cells.

    Paul Hasty;Jaime A. Rivera-Pérez;Allan Bradley

  • ERCC1-XPF Endonuclease Facilitates DNA Double-Strand Break Repair

    Anwaar Ahmad;Andria Rasile Robinson;Anette Duensing;Ellen van Drunen

  • Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells.

    Paul Hasty;Jaime A. Rivera-Pérez;Christine Chang;Allan Bradley

  • Defective embryonic neurogenesis in Ku-deficient but not DNA-dependent protein kinase catalytic subunit-deficient mice.

    Yansong Gu;JoAnn Sekiguchi;Yijie Gao;Pieter Dikkes

  • Ku is a 5′-dRP/AP lyase that excises nucleotide damage near broken ends

    Steven A. Roberts;Natasha Strande;Martin D. Burkhalter;Christina Strom

  • Methods for the genetic modification of endogenous genes in animal cells by homologous recombination

    Allan Bradley;Ann Davis;Paul Hasty

  • Analysis of ku80-Mutant Mice and Cells with Deficient Levels of p53

    Dae Sik Lim;Hannes Vogel;Dennis M. Willerford;Arthur T. Sands

  • Targeted Mutation in β1,4-Galactosyltransferase Leads to Pituitary Insufficiency and Neonatal Lethality

    Qingxian Lu;Paul Hasty;Barry D. Shur

  • The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage.

    E M Bahassi;J L Ovesen;A L Riesenberg;W Z Bernstein

  • Targeting frequency for deletion vectors in embryonic stem cells.

    Hongbing Zhang;Paul Hasty;Allan Bradley

  • Modifying the mouse: design and desire.

    Allan Bradley;Paul Hasty;Ann Davis;Ramiro Ramirez-Solis

  • Deletion of Ku70, Ku80, or Both Causes Early Aging without Substantially Increased Cancer

    Han Li;Hannes Vogel;Valerie B. Holcomb;Yansong Gu

  • A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus

    Wanda K. O'Neal;Paul Hasty;Paul B. McCray Jr.;Brett Casey

Frequent Co-Authors

Allan Bradley
Allan Bradley University of Cambridge
Jan Vijg
Jan Vijg Albert Einstein College of Medicine
Judith Campisi
Judith Campisi Buck Institute for Research on Aging
Tyler J. Curiel
Tyler J. Curiel The University of Texas at San Antonio
Hannes Vogel
Hannes Vogel Stanford University
Jan H.J. Hoeijmakers
Jan H.J. Hoeijmakers Erasmus University Rotterdam
Dae-Sik Lim
Dae-Sik Lim Korea Advanced Institute of Science and Technology
Yang Liu
Yang Liu University of Michigan–Ann Arbor
Martin A. Javors
Martin A. Javors The University of Texas Health Science Center at San Antonio
Frank L. Graham
Frank L. Graham McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Molecular Biology opens up a range of professional opportunities, both in and out of the lab. For those interested in expanding their career options or moving into healthcare leadership, online degree pathways offer flexible alternatives.

Many consider bridge programs such as asn to np for a streamlined route from nursing to advanced practice roles. Similarly, individuals without a nursing background may be interested in direct entry msn programs online, which allow non-nurses to enter nursing at the master’s level.

If you already have some nursing credentials, you might compare popular universities for online programs. Debating which school is better snhu vs wgu can help find the best fit for your educational and career goals.

For nurses holding a BSN, looking for affordable advancement, bsn to msn bridge programs offer an efficient way to earn a master’s degree and unlock higher-level positions in healthcare or research.

Best Scientists Citing Paul Hasty

Trending Scientists